RééDOC
75 Boulevard Lobau
54042 NANCY cedex

Christelle Grandidier Documentaliste
03 83 52 67 64


F Nous contacter

0

Article

--";3! O
     

-A +A

Patient-reported upper extremity outcome measures used in breast cancer survivors

HARRINGTON S; MICHENER L; KENDIG T; MIALE S; GEORGE SZ
ARCH PHYS MED REHABIL , 2014, vol. 95, n° 1, p. 153-162
Doc n°: 169328
Localisation : Documentation IRR

D.O.I. : http://dx.doi.org/DOI:10.1016/j.apmr.2013.07.022
Descripteurs : MB - CANCEROLOGIE, DD15 - PATHOLOGIE - MEMBRE SUPERIEUR
Article consultable sur : http://www.archives-pmr.org

OBJECTIVES: (1) To identify English-language published patient-reported upper
extremity outcome measures used in breast cancer research and (2) to examine
construct validity and responsiveness in patient-reported upper extremity outcome
measures used in breast cancer research. DATA SOURCES: PubMed, Cumulative Index
to Nursing and Allied Health Literature, and ProQuest MEDLINE databases were
searched up to February 5, 2013. STUDY SELECTION: Studies were included if a
patient-reported upper extremity outcome measure was administered, the
participants were diagnosed with breast cancer, and the study was published in
English. DATA EXTRACTION: A total of 865 articles were screened. Fifty-nine full
text articles were assessed for eligibility. A total of 46 articles met the
initial eligibility criteria for aim 1. Eleven of these articles reported means
and SDs for the outcome scores and included a comparison group analysis for aim
2. DATA SYNTHESIS: Construct validity was evaluated by calculating effect sizes
for known-group differences in 6 studies using the Disabilities of Arm, Shoulder
and Hand (DASH), University of Pennsylvania Shoulder Score, Shoulder Disability
Questionnaire-Dutch, and 10 Questions by Wingate. Responsiveness was analyzed
comparing a treatment and control group by calculating the coefficient of
responsiveness in 5 studies for the DASH and 10 Questions by Wingate.
CONCLUSIONS: Eight different patient-reported upper extremity outcome measures
have been reported in the peer-review literature for women with breast cancer;
some that were specifically developed for breast cancer survivors (n=3) and
others that were not (n=5). Based on the current evidence, we recommend
administering the DASH to assess patient-reported upper extremity function in
breast cancer survivors because the DASH has the most consistently large effects
sizes for construct validity and responsiveness. Future large studies are needed
for more definitive recommendations.
CI - Copyright (c) 2014 American Congress of Rehabilitation Medicine. Published by
Elsevier Inc. All rights reserved.

Langue : ANGLAIS

Mes paniers

4

Gerer mes paniers

0